Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001 Apr 9;2(2):E6.
doi: 10.1208/pt020206.

Effect of hydroxypropyl methylcellulose and hydrogenated castor oil on naproxen release from sustained-release tablets

Affiliations

Effect of hydroxypropyl methylcellulose and hydrogenated castor oil on naproxen release from sustained-release tablets

M H Amaral et al. AAPS PharmSciTech. .

Abstract

The effect of the concentration of hydrophilic (hydroxypropyl methylcellulose [HPMC]) and hydrophobic (hydrogenated castor oil [HCO]) products, fillers (lactose and dibasic calcium phosphate), and buffers (sodium bicarbonate, calcium carbonate, and sodium citrate) on naproxen release rate was studied. Matrix tablets were prepared by double compression, and in vitro dissolution tests were performed. The dissolution results showed that an increased amount of HPMC or hydrogenated castor oil resulted in reduced drug release. The inclusion of buffers in the HPMC matrix tablets enhanced naproxen release. For HCO tablets, only sodium bicarbonate enhanced naproxen release. The presence of lactose on HPMC matrix tablets did not show a significantly different result from that obtained with the formulation containing dibasic calcium phosphate as a filler. However, for the tablets containing HCO, the presence of lactose significantly enhanced the naproxen release rate. The matrix-forming materials in this study were suitable for use in sustained-release tablets containing naproxen. The drug release can be modulated by adding suitable amounts of diluents and buffers.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Todd PA, Clissold SP. Naproxen: a reappraisal of its pharmacology, and use in rheumatic diseases and pain states. Drugs. 1990;40:91–137. - PubMed
    1. Pather S, Russell I, Syce J, Neau S. Sustained release theophylline tablets by direct compression, Part 1: formulation andIn vitro testing. Int J Pharm. 1998;164:1–10. doi: 10.1016/S0378-5173(97)00348-7. - DOI
    1. Salsa T, Veiga F, Pina mE. Oral controlled-release dosage forms. I. Cellulose ether polymers in hydrophilic matrices. Drug Dev Ind Pharm. 1997;23:929–938. doi: 10.3109/03639049709148697. - DOI - PubMed
    1. Kibbe A. Handbook of Pharmaceutical Excipients. Washington: American Pharmaceutical Association and The Pharmaceutical Society of Great Britain; 1986. pp. 49–50.
    1. Lachman L, Lieberman HA, Kanig JL. Pharmaceutical Dosage Forms-Tablets. 2nd ed. New York: marcel Dekker Inc; 1989. pp. 13–13.

Publication types

LinkOut - more resources